Search - tctmd.com

Displaying 121 - 140 of 264

Sort: Relevancy | Date

COVID-19: TCTMD’s Dispatch for October Week 2

News Daily News

COVID-19: TCTMD’s Dispatch for October Week 2

October 11, 2021

Vasopressor/Steroid Combo Jump-starts Circulation for In-Hospital Cardiac Arrests

News Daily News

Vasopressor/Steroid Combo Jump-starts Circulation for In-Hospital Cardiac Arrests

September 30, 2021

COVID-19: TCTMD’s Dispatch for September Week 5

News Daily News

COVID-19: TCTMD’s Dispatch for September Week 5

September 27, 2021

Fixed-Dose Combo Therapy Slashes CVD Risk in Primary Prevention

News Conference News ESC 2021

Fixed-Dose Combo Therapy Slashes CVD Risk in Primary Prevention

Michael O'Riordan

August 31, 2021

‘Quadpill’ Beats Monotherapy at BP Lowering: QUARTET

News Conference News ESC 2021

‘Quadpill’ Beats Monotherapy at BP Lowering: QUARTET

August 31, 2021

Finerenone Reduces CV Outcomes in Patients With Early CKD, Diabetes: FIGARO-DKD

News Conference News ESC 2021

Finerenone Reduces CV Outcomes in Patients With Early CKD, Diabetes: FIGARO-DKD

Michael O'Riordan

August 28, 2021

Milrinone, Dobutamine Comparable for Cardiogenic Shock: DOREMI

News Daily News

Milrinone, Dobutamine Comparable for Cardiogenic Shock: DOREMI

August 10, 2021

Therapeutic-Dose Heparin in COVID-19: Who Benefits, Who Doesn’t

News Daily News

Therapeutic-Dose Heparin in COVID-19: Who Benefits, Who Doesn’t

August 04, 2021

High Ischemic Risk and Bleeding Risk: A Delicate Balance Post-PCI

News Conference News EAS 2021

High Ischemic Risk and Bleeding Risk: A Delicate Balance Post-PCI

Michael O'Riordan

June 08, 2021

Sotagliflozin Beneficial Across a Range of Patients, Including HFpEF

News Conference News ACC 2021

Sotagliflozin Beneficial Across a Range of Patients, Including HFpEF

Michael O'Riordan

May 25, 2021

Hormone Cancer Therapies Increase CV Risk: AHA Scientific Statement

News Daily News

Hormone Cancer Therapies Increase CV Risk: AHA Scientific Statement

Yael L. Maxwell

April 26, 2021

Dual Bests Triple Therapy in Nonvalvular AF Patients in RE-DUAL PCI

News Daily News

Dual Bests Triple Therapy in Nonvalvular AF Patients in RE-DUAL PCI

Yael L. Maxwell

April 09, 2021

AI in Cardiology: Where We Are Now and Where to Go Next

News Features

AI in Cardiology: Where We Are Now and Where to Go Next

Yael L. Maxwell

March 30, 2021

Popularity vs Reputation: Content Matters for #CardioTwitter

News Daily News

Popularity vs Reputation: Content Matters for #CardioTwitter

March 23, 2021

VITAL RHYTHM in Print: Dose Effects of Omega-3s on AF Still Unclear

News Daily News

VITAL RHYTHM in Print: Dose Effects of Omega-3s on AF Still Unclear

March 17, 2021

Antiplatelets, Especially Cilostazol, Helpful in Moyamoya Arteriopathy

News Daily News

Antiplatelets, Especially Cilostazol, Helpful in Moyamoya Arteriopathy

Michael O'Riordan

February 26, 2021

Rivaroxaban-Aspirin Combo Works in ASCVD Across BMI Groups

News Daily News

Rivaroxaban-Aspirin Combo Works in ASCVD Across BMI Groups

February 01, 2021

Vitamin D, Calcium, Other Vitamins, and Supplements Do Not Prevent CVD

News Daily News

Vitamin D, Calcium, Other Vitamins, and Supplements Do Not Prevent CVD

Michael O'Riordan

January 25, 2021

Hospitalization for HF After Acute MI More Common in Women Than Men

News Daily News

Hospitalization for HF After Acute MI More Common in Women Than Men

January 15, 2021

ACE Inhibitors, ARBs: Still No Link to COVID-19 Risks, New Analyses Show

News Daily News

ACE Inhibitors, ARBs: Still No Link to COVID-19 Risks, New Analyses Show

Michael O'Riordan

December 21, 2020

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.